Ian Shakil's most recent trade in Augmedix Inc was a trade of 3,750 Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,750 | 9,113 | - | - | Common Stock | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,750 | 52,500 | - | - | Restricted Stock Units | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 15 Aug 2024 | 1,412 | 7,701 | - | 2.3 | 3,205 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,750 | 6,750 | - | - | Common Stock | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,750 | 56,250 | - | - | Restricted Stock Units | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 15 May 2024 | 1,387 | 5,363 | - | 1.2 | 1,651 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 60,000 | 120,000 | - | - | Restricted Stock Units | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 3,750 | 11,451 | - | - | Common Stock | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 3,750 | 116,250 | - | - | Restricted Stock Units | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 07 May 2024 | 1,412 | 10,039 | - | 2.3 | 3,205 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.80 per share. | 15 Apr 2024 | 500 | 3,000 | - | 3.8 | 1,900 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 500 | 455,949 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 15 Apr 2024 | 500 | 3,500 | - | 0.9 | 430 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.82 per share. | 12 Apr 2024 | 19,544 | 3,000 | - | 3.8 | 74,590 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 12 Apr 2024 | 19,544 | 22,544 | - | 0.9 | 16,808 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2024 | 19,544 | 456,449 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 09 Apr 2024 | 36,467 | 3,000 | - | 3.9 | 141,288 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 09 Apr 2024 | 36,467 | 39,467 | - | 0.9 | 31,362 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 36,467 | 500,771 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 09 Apr 2024 | 31,542 | 3,000 | - | 4.1 | 130,521 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 24,778 | 475,993 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.93 per share. | 09 Apr 2024 | 24,778 | 3,000 | - | 3.9 | 97,477 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 09 Apr 2024 | 24,778 | 27,778 | - | 0.9 | 21,309 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 09 Apr 2024 | 17,186 | 34,542 | - | 0.9 | 14,780 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 17,186 | 537,238 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 14,356 | 0 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 09 Apr 2024 | 14,356 | 17,356 | - | 0.6 | 9,188 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 05 Apr 2024 | 51,387 | 12,217 | - | 4.0 | 207,233 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.97 per share. | 05 Apr 2024 | 28,563 | 12,217 | - | 4.0 | 113,381 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 28,563 | 14,356 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 05 Apr 2024 | 28,563 | 40,780 | - | 0.6 | 18,280 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.97 per share. | 05 Apr 2024 | 9,217 | 3,000 | - | 4.0 | 36,587 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 03 Apr 2024 | 64,055 | 31,610 | - | 4.2 | 265,854 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.11 per share. | 03 Apr 2024 | 45,906 | 95,665 | - | 4.1 | 188,600 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 51,346 | 42,919 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 01 Apr 2024 | 51,346 | 187,666 | - | 3.9 | 199,685 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 01 Apr 2024 | 51,346 | 239,012 | - | 0.6 | 32,861 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 01 Apr 2024 | 38,463 | 141,571 | - | 3.9 | 149,725 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 01 Apr 2024 | 7,632 | 180,034 | - | 4.0 | 30,699 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 28 Mar 2024 | 31,994 | 187,666 | - | 4.1 | 129,851 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 28 Mar 2024 | 31,994 | 251,654 | - | 0.6 | 20,476 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 28 Mar 2024 | 31,994 | 219,660 | - | 4.1 | 129,851 | Common Stock |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 31,994 | 94,265 | - | - | Stock Option (Right to Buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Augmedix Inc | Ian Shakil | Director, CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Augmedix Inc | Ian Shakil | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy | |
| Augmedix Inc | Ian Shakil | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 3.40 per share. | 03 Dec 2021 | 3,000 | 219,660 | - | 3.4 | 10,200 | Common Stock |